Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Geoghegan

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Oncogene|June 29, 2004
Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factorGang Dong, Tin Lap Lee, Ning T Yeh, et al.
Diagnostics (Basel, Switzerland)|January 14, 2021
Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too LateMaarten J IJzerman, Jasper de Boer, Arun Azad, et al.
BMC Genomics|May 7, 2005
Three microarray platforms: an analysis of their concordance in profiling gene expressionDavid Petersen, G V R Chandramouli, Joel Geoghegan, et al.
Human Mutation|July 30, 2013
Detection of clinically relevant copy number variants with whole-exome sequencingJoep de Ligt, Philip M Boone, Rolph Pfundt, et al.
Plos Genetics|October 27, 2015
HENMT1 and piRNA Stability Are Required for Adult Male Germ Cell Transposon Repression and to Define the Spermatogenic Program in the MouseShu Ly Lim, Zhi Peng Qu, R Daniel Kortschak, et al.
Journal of the Endocrine Society|November 16, 2020
Aberrant Splicing of <i>SDHC</i> in Families With Unexplained Succinate Dehydrogenase-Deficient ParagangliomasSunita M C De Sousa, John Toubia, Tristan S E Hardy, et al.
Nature Genetics|August 21, 2007
Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2Blake C Ballif, Sara A Hornor, Elizabeth Jenkins, et al.
Annals of Neurology|October 28, 2015
Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsyMichael G Ricos, Bree L Hodgson, Tommaso Pippucci, et al.
Nature Methods|April 23, 2005
Multiple-laboratory comparison of microarray platformsRafael A Irizarry, Daniel Warren, Forrest Spencer, et al.
Leukemia|May 16, 2019
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distributionDeepak Singhal, Li Yan A Wee, Monika M Kutyna, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Oncogene|June 29, 2004
Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factorGang Dong, Tin Lap Lee, Ning T Yeh, et al.
Diagnostics (Basel, Switzerland)|January 14, 2021
Towards Routine Implementation of Liquid Biopsies in Cancer Management: It Is Always Too Early, until Suddenly It Is Too LateMaarten J IJzerman, Jasper de Boer, Arun Azad, et al.
BMC Genomics|May 7, 2005
Three microarray platforms: an analysis of their concordance in profiling gene expressionDavid Petersen, G V R Chandramouli, Joel Geoghegan, et al.
Human Mutation|July 30, 2013
Detection of clinically relevant copy number variants with whole-exome sequencingJoep de Ligt, Philip M Boone, Rolph Pfundt, et al.
Plos Genetics|October 27, 2015
HENMT1 and piRNA Stability Are Required for Adult Male Germ Cell Transposon Repression and to Define the Spermatogenic Program in the MouseShu Ly Lim, Zhi Peng Qu, R Daniel Kortschak, et al.
Journal of the Endocrine Society|November 16, 2020
Aberrant Splicing of <i>SDHC</i> in Families With Unexplained Succinate Dehydrogenase-Deficient ParagangliomasSunita M C De Sousa, John Toubia, Tristan S E Hardy, et al.
Nature Genetics|August 21, 2007
Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2Blake C Ballif, Sara A Hornor, Elizabeth Jenkins, et al.
Annals of Neurology|October 28, 2015
Mutations in the mammalian target of rapamycin pathway regulators NPRL2 and NPRL3 cause focal epilepsyMichael G Ricos, Bree L Hodgson, Tommaso Pippucci, et al.
Nature Methods|April 23, 2005
Multiple-laboratory comparison of microarray platformsRafael A Irizarry, Daniel Warren, Forrest Spencer, et al.
Leukemia|May 16, 2019
The mutational burden of therapy-related myeloid neoplasms is similar to primary myelodysplastic syndrome but has a distinctive distributionDeepak Singhal, Li Yan A Wee, Monika M Kutyna, et al.
Pageof 2